Curative effect of mediopatellar plica syndrome under different therapies
10.3969/j.issn.1007-1989.2017.06.002
- VernacularTitle:不同方案治疗单纯髌内侧滑膜皱襞综合征的疗效差异
- Author:
Junjun YANG
;
Yizhao ZHOU
;
Shu HUANG
;
Duo XIA
;
Baorong LIU
- Keywords:
mediopatellar plica syndrome;
physicotherapeutics;
intraarticular injection;
arthroscopy
- From:
China Journal of Endoscopy
2017;23(6):7-11
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare and analyze the curative effects of mediopatellar plica syndrome under different therapies. Methods 147 patients with mediopatellar plica syndrome were enrolled in the study from January 2011 to January 2015 and divided into three groups refer to treatment: Group A, B and C. Each group was also divided in the youth group and the mid-age group. Different treatments were used in the three groups. Group A: drug therapy and physicotherapeutics; Group B: intraarticular injection regularly; Group C: arthroscopic surgical treatment. All patient conditions were assessed with Lysholm score. Results All patients received an average of 11 (9 ~ 13) months follow-up. No blood-vessel and nerve injured and infection occurred. Before receiving treatment, difference in Lysholm score of the three groups showed no statistical difference (F = 0.08, P = 0.926); after treatment, difference revealed significant difference (F = 15.48, P = 0.001). Compared with those before operation and after operation among the three groups, the Lysholm score was improved (tA = 3.43, tB = 6.74, tC = 7.99, P = 0.001). In the rangeability of Lysholm score, the Group C > B > A (F = 66.43, tAB = 5.97, tAC = 11.52, tBC = 5.55, P = 0.001);The general youth group > the general mid-age (t = 7.91, P = 0.001). Conclusion The best therapeutic method for mediopatellar plica syndrome is the arthroscopy. As for mid-age patients, it is necessary to inform them of possibility that prognosis is not well in preoperative planning.
